SOMERSET, N.J., Feb. 19, 2013 /PRNewswire/ -- Terumo Medical
Corporation (Terumo), today announced that it has filed a patent
infringement lawsuit against Vascular Solutions Inc. and Lepu
Medical Technology (Beijing) Co.,
Ltd in the U.S. District Court of New
Jersey.
The complaint alleges that R Band™ Radial Hemostasis Device
distributed by Vascular Solutions and manufactured by Lepu Medical
Technology infringes on a patent and trademark, which Terumo
Medical Corporation holds the U.S. rights to for its proprietary TR
Band™ Radial Compression Device. Terumo seeks an injunction
against further sales of the violative product.
"Terumo has made an enormous investment in developing
intellectual property and absorbing costs associated with device
design and commercialization of our transradial technology. The
Terumo TR Band™ device is a critical part of our transradial
solutions portfolio. We will vigorously take all steps
necessary to ensure that our assets and intellectual property are
protected," said Gael Tisack, Vice
President of Intellectual Property, Terumo Americas Holding.
Terumo Interventional Systems
Terumo Interventional
Systems (TIS) is a strategic business unit of Terumo Medical
Corporation. As a market leader in entry site management and lesion
access, TIS is committed to pursuing unique technologies designed
to enhance treatment of coronary and peripheral endovascular
diseases as well as driving strategic initiatives focused on
Critical Limb Ischemia, Complex Coronary Intervention and
Transradial Access.
TIS directly markets a full line of guidewires, catheters,
introducer sheaths, guiding sheaths and embolization products for
use in a multitude of different interventional procedures.
Terumo Medical Corporation
Founded in 1972 as a Terumo
Corporation subsidiary, Terumo Medical Corporation (TMC) develops,
manufactures, and markets a complete, solutions-based portfolio of
high-quality medical devices used in a broad range of applications
for numerous areas of the healthcare industry. TMC is
comprised of two business divisions: Terumo Interventional
Systems and Terumo Medical Products. The company places a premium
on providing customers with world-class products, training and
education programs that drive clear economic value, better clinical
outcomes and improved Quality of Life for patients.
Terumo Corporation
Tokyo-based Terumo Corporation is one of the
world's leading medical device manufacturers with
$5 billion in sales and operations in
more than 160 nations. Founded in 1921, the company develops,
manufactures, and distributes world-class medical devices including
products for use in cardiothoracic surgery, interventional
procedures, and transfusion medicine; the company also manufactures
a broad array of syringe and hypodermic needle products for
hospital and physician office use. Terumo contributes to society by
providing valued products and services to the healthcare market and
by responding to the needs of healthcare providers and the people
they serve.
Terumo Corporation's shares are listed on the first section of the
Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or
Bloomberg 4543: JP) and is a component of the Nikkei 225,
Japan's leading stock index.
SOURCE Terumo Interventional Systems
